About
Diadem Biotherapeutics engineers extracellular vesicles to modulate immune cell receptors, aiming to develop therapies for cancer and autoimmune diseases using their DECOSTAR™ platform.
Explore Diadem Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.